Baxter Bros Inc’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,750
| Closed | -$408K | – | 161 |
|
|
2023
Q4 | $408K | Hold |
13,750
| – | – | 0.06% | 114 |
|
|
2023
Q3 | $218K | Hold |
13,750
| – | – | 0.03% | 138 |
|
|
2023
Q2 | $259K | Sell |
13,750
-71,800
| -84% | -$848K | 0.04% | 120 |
|
|
2023
Q1 | $329K | Hold |
85,550
| – | – | 0.05% | 114 |
|
|
2022
Q4 | $424K | Sell |
85,550
-1,450
| -2% | -$7.86K | 0.07% | 102 |
|
|
2022
Q3 | $416K | Hold |
87,000
| – | – | 0.07% | 95 |
|
|
2022
Q2 | $391K | Hold |
87,000
| – | – | 0.07% | 91 |
|
|
2022
Q1 | $414K | Buy |
87,000
+200
| +0.2% | +$1.11K | 0.06% | 98 |
|
|
2021
Q4 | $644K | Sell |
86,800
-1,500
| -2% | -$9.32K | 0.09% | 82 |
|
|
2021
Q3 | $501K | Hold |
88,300
| – | – | 0.08% | 87 |
|
|
2021
Q2 | $582K | Buy |
88,300
+1,500
| +2% | +$10.5K | 0.09% | 80 |
|
|
2021
Q1 | $703K | Sell |
86,800
-500
| -0.6% | -$4.08K | 0.12% | 78 |
|
|
2020
Q4 | $563K | Sell |
87,300
-1,000
| -1% | -$5.83K | 0.11% | 80 |
|
|
2020
Q3 | $318K | Hold |
88,300
| – | – | 0.07% | 94 |
|
|
2020
Q2 | $406K | Hold |
88,300
| – | – | 0.1% | 86 |
|
|
2020
Q1 | $301K | Buy |
88,300
+10,000
| +13% | +$43.7K | 0.08% | 90 |
|
|
2019
Q4 | $400K | Hold |
78,300
| – | – | 0.08% | 95 |
|
|
2019
Q3 | $189K | Hold |
78,300
| – | – | 0.04% | 109 |
|
|
2019
Q2 | $170K | Buy |
78,300
+11,000
| +16% | +$26K | 0.04% | 114 |
|
|
2019
Q1 | $182K | Buy |
67,300
+38,500
| +134% | +$167K | 0.04% | 107 |
|
|
2018
Q4 | $138K | Sell |
28,800
-2,000
| -6% | -$12.1K | 0.04% | 107 |
|
|
2018
Q3 | $292K | Hold |
30,800
| – | – | 0.07% | 99 |
|
|
2018
Q2 | $300K | Sell |
30,800
-25,000
| -45% | -$264K | 0.08% | 97 |
|
|
2018
Q1 | $587K | Sell |
55,800
-2,200
| -4% | -$21.7K | 0.16% | 82 |
|
|
2017
Q4 | $372K | Hold |
58,000
| – | – | 0.1% | 94 |
|
|
2017
Q3 | $444K | Hold |
58,000
| – | – | 0.13% | 85 |
|
|
2017
Q2 | $412K | Hold |
58,000
| – | – | 0.12% | 88 |
|
|
2017
Q1 | $224K | Buy |
58,000
+10,000
| +21% | +$29.2K | 0.07% | 103 |
|
|
2016
Q4 | $98K | Buy |
48,000
+14,000
| +41% | +$28.1K | 0.03% | 105 |
|
|
2016
Q3 | $91K | Buy |
34,000
+15,300
| +82% | +$44.5K | 0.03% | 109 |
|
|
2016
Q2 | $58K | Buy |
+18,700
| New | +$117K | 0.02% | 104 |
|
|
2015
Q4 | $281K | Buy |
20,700
+2,000
| +11% | +$24.6K | 0.1% | 100 |
|
|
2015
Q3 | $269K | Hold |
18,700
| – | – | 0.1% | 99 |
|
|
2015
Q2 | $269K | Hold |
18,700
| – | – | 0.1% | 99 |
|
|
2015
Q1 | $167K | Buy |
+18,700
| New | +$135K | 0.06% | 111 |
|
Other funds holding IMGN
Baxter Bros Inc's IMGN Position: Q1 2024 in Review
Baxter Bros Inc sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 13,750 shares — an estimated $408K sold.
Baxter Bros Inc first reported a position in IMGN in Q1 2015 and held it in 35 quarters. The position peaked at $703K in Q1 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Baxter Bros Inc reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Baxter Bros Inc sold 13,750 Immunogen Inc shares in Q1 2024, an estimated $408K.
- Baxter Bros Inc first reported a position in Immunogen Inc in Q1 2015 and held it in 35 quarters.
- Baxter Bros Inc's Immunogen Inc position peaked at $703K in Q1 2021.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Baxter Bros Inc's 13F filing for Q1 2024, filed 29 Apr 2024.